Viridian Therapeutics, Inc.\DE

VRDN

Form 4/A • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001193125-26-092065
Filing date: Mar 4, 2026
Earliest execution date:
Reporting Owners: Tousignant Jennifer (Chief Legal Officer)
SEC Filing link

Summary

Type

Neutral

Net shares

0

% of shares

0.00%

Amount (USD)

$0

Insider confidence score

52.5 out of 100

Positive

  • Minimal sell amount (<$10K)

Filing's footnotes

1. This amendment is being filed to correct the number of shares beneficially owned by the Reporting Person as reported in the original Form 4 filed with the Securities and Exchange Commission on March 4, 2025, which inadvertently omitted an aggregate of 610 shares purchased under the Viridian Therapeutics, Inc. 2016 Employee Stock Purchase Plan.

⚠️ This is a correction filing

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.